Aerie Pharmaceuticals Inc

Swiss National Bank

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/9/2022

Shares

103,800

Value ($000)

1,570

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/9/2022	1,570	0.0%	103,800	9/30/2022
2022 Q2	8/9/2022	770	0.0%	102,600	6/30/2022
2022 Q1	5/9/2022	967	0.0%	106,300	3/31/2022
2021 Q4	2/8/2022	688	0.0%	98,000	12/31/2021
2021 Q3	11/8/2021	1,117	0.0%	98,000	9/30/2021
2021 Q2	8/6/2021	1,569	0.0%	98,000	6/30/2021
2021 Q1	5/7/2021	1,626	0.0%	91,000	3/31/2021
2020 Q4	2/5/2021	1,208	0.0%	89,400	12/31/2020
2020 Q3	11/9/2020	1,037	0.0%	88,100	9/30/2020
2020 Q2	8/5/2020	1,300	0.0%	88,100	6/30/2020
2020 Q1	5/8/2020	1,150	0.0%	85,200	3/31/2020
2019 Q4	2/6/2020	2,018	0.0%	83,500	12/31/2019